Cencora
LSE: 0HF3.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Robert Mauch
- Employees
- 42,000
- Headquarters
- Conshohocken, United States
- IPO year
- 2018
- Market cap
- $51.0B
- Website
- https://www.amerisourcebergen.com
Loading 0HF3…
Loading profile data…Frequently asked questions about 0HF3
What does Cencora (0HF3.L) do?
Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical cl...
Where does 0HF3.L trade?
Cencora (0HF3.L) trades on the London Stock Exchange.
What sector is 0HF3.L in?
Cencora (0HF3.L) operates in the Healthcare sector, specifically in the Medical - Distribution industry.
Who is the CEO of Cencora?
Robert Mauch is the chief executive officer of Cencora (0HF3.L).
Where is Cencora headquartered?
Cencora is headquartered in United States.
Does 0HF3.L pay a dividend?
Yes — Cencora (0HF3.L) paid a trailing twelve-month dividend of USD 2.30 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 0HF3.L go public?
Cencora (0HF3.L) completed its initial public offering in 2018.